![A Pregnant Woman Never Drinks Alone. Visit zeroexposure.org The Zero Exposure Project Presented by Lisa Colen, MHA ZEP Director. - ppt download A Pregnant Woman Never Drinks Alone. Visit zeroexposure.org The Zero Exposure Project Presented by Lisa Colen, MHA ZEP Director. - ppt download](https://images.slideplayer.com/15/4579687/slides/slide_25.jpg)
A Pregnant Woman Never Drinks Alone. Visit zeroexposure.org The Zero Exposure Project Presented by Lisa Colen, MHA ZEP Director. - ppt download
![Validation of the 4P's Plus© screen for substance use in pregnancy validation of the 4P's Plus | Journal of Perinatology Validation of the 4P's Plus© screen for substance use in pregnancy validation of the 4P's Plus | Journal of Perinatology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.jp.7211823/MediaObjects/41372_2007_Article_BF7211823_Fig1_HTML.gif)
Validation of the 4P's Plus© screen for substance use in pregnancy validation of the 4P's Plus | Journal of Perinatology
![All-trans retinoic acid plus high-dose dexamethasone as first-line treatment for patients with newly diagnosed immune thrombocytopenia: a multicentre, open-label, randomised, controlled, phase 2 trial - The Lancet Haematology All-trans retinoic acid plus high-dose dexamethasone as first-line treatment for patients with newly diagnosed immune thrombocytopenia: a multicentre, open-label, randomised, controlled, phase 2 trial - The Lancet Haematology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/0a920e8d-fd31-4644-858c-66e668a32107/gr1.gif)
All-trans retinoic acid plus high-dose dexamethasone as first-line treatment for patients with newly diagnosed immune thrombocytopenia: a multicentre, open-label, randomised, controlled, phase 2 trial - The Lancet Haematology
![The Underappreciated Role of Low Muscle Mass in the Management of Malnutrition - Journal of the American Medical Directors Association The Underappreciated Role of Low Muscle Mass in the Management of Malnutrition - Journal of the American Medical Directors Association](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/20b1c165-89d7-48fc-a747-3a29152301ed/gr1_lrg.jpg)
The Underappreciated Role of Low Muscle Mass in the Management of Malnutrition - Journal of the American Medical Directors Association
![Barbara May RN, MPH Director, Prevention Programs Southern New Jersey Perinatal Cooperative PRESENTER Influencing State Health Policy Influencing State. - ppt download Barbara May RN, MPH Director, Prevention Programs Southern New Jersey Perinatal Cooperative PRESENTER Influencing State Health Policy Influencing State. - ppt download](https://images.slideplayer.com/36/10567386/slides/slide_12.jpg)
Barbara May RN, MPH Director, Prevention Programs Southern New Jersey Perinatal Cooperative PRESENTER Influencing State Health Policy Influencing State. - ppt download
![Figure 1 from The 4P's Plus© Screen for Substance Use in Pregnancy: Clinical Application and Outcomes | Semantic Scholar Figure 1 from The 4P's Plus© Screen for Substance Use in Pregnancy: Clinical Application and Outcomes | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ea575e6623c8d2b583ae75e04c4cfe32d08642c7/2-Figure1-1.png)
Figure 1 from The 4P's Plus© Screen for Substance Use in Pregnancy: Clinical Application and Outcomes | Semantic Scholar
![Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma | Nature Medicine Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-020-1086-y/MediaObjects/41591_2020_1086_Fig1_HTML.png)
Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma | Nature Medicine
![The 4P's Plus© Screen for Substance Use in Pregnancy: Clinical Application and Outcomes | Journal of Perinatology The 4P's Plus© Screen for Substance Use in Pregnancy: Clinical Application and Outcomes | Journal of Perinatology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fsj.jp.7211266/MediaObjects/41372_2005_Article_BF7211266_Fig1_HTML.gif)